Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)
Clinical trial NCT00092417 · COMPLETED
Trial details
- NCT number
- NCT00092417
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-06-01
- Enrollment
- 695
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.